Customization of therapy for gastroesophageal adenocarcinoma patients
Gastroesophageal adenocarcinomas (GEACs) remain a global health problem. These are most often diagnosed at advanced stage and the estimated 5-year relative survival rate is about 5%. Although cure is not possible for patients with advanced GEAC, systemic therapy (chemotherapy or biochemotherapy) can...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/67582d5f1347400690565480df29ae11 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|